Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001230848 | SCV001403347 | uncertain significance | Joubert syndrome 14 | 2022-10-24 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the TMEM237 mRNA. The next in-frame methionine is located at codon 206. This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with TMEM237-related conditions. ClinVar contains an entry for this variant (Variation ID: 957799). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002241358 | SCV002511584 | uncertain significance | not specified | 2022-04-01 | criteria provided, single submitter | clinical testing | Variant summary: TMEM237 c.1A>G (p.Met1Val) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon (next methionine is located at codon 206). Two of three in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-05 in 126266 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1A>G in individuals affected with Joubert Syndrome And Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. A ClinVar submitter (evaluation after 2014) cites the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Fulgent Genetics, |
RCV001230848 | SCV005654505 | likely pathogenic | Joubert syndrome 14 | 2024-01-12 | criteria provided, single submitter | clinical testing |